BioNTech
BNTX
BNTX
279 hedge funds and large institutions have $4.34B invested in BioNTech in 2023 Q4 according to their latest regulatory filings, with 70 funds opening new positions, 90 increasing their positions, 69 reducing their positions, and 37 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
279
Holders Change
+31
Holders Change %
+12.5%
% of All Funds
4.09%
Holding in Top 10
4
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.06%
New
70
Increased
90
Reduced
69
Closed
37
Calls
$234M
Puts
$224M
Net Calls
+$10.8M
Net Calls Change
+$12.2M
Top Buyers
| 1 |
HL
Harding Loevner
Bridgewater,
New Jersey
|
$411M |
| 2 |
Morgan Stanley
New York
|
$133M |
| 3 |
Squarepoint
New York
|
$33.4M |
| 4 |
Amundi
Paris,
France
|
$26.9M |
| 5 |
UBS AM
Chicago,
Illinois
|
$105M |
